GlobeNewswire Inc.··NaRelay Therapeutics to Report 2025 Results Ahead of Phase 3 Pipeline Milestones
Relay Therapeutics reports 2025 results February 26, highlighting progress on lead drug zovegalisib advancing through Phase 3 trials with FDA Breakthrough Therapy Designation.
RLAYPhase 3 clinical trialFDA Breakthrough Therapy Designation